
Non Invasive Prenatal Testing (NIPT) - PrenatalSAFE Karyo
Understanding Non Invasive Prenatal Testing (NIPT)
Non Invasive Prenatal Testing (NIPT) - PrenatalSAFE Karyo is a groundbreaking method used to assess the risk of certain genetic disorders in a fetus, such as Down syndrome. This testing method is non-invasive, meaning that it involves a simple blood draw from the mother. Because of this, there are no risks associated with amniocentesis or chorionic villus sampling, which can be more invasive and carry potential complications. NIPT uses advanced DNA analysis to evaluate fragments of fetal DNA present in the mother's bloodstream, providing a reliable indicator of chromosomal abnormalities.
The Benefits of PrenatalSAFE Karyo
One of the main benefits of PrenatalSAFE Karyo is its high accuracy rate, often exceeding 99% in detecting conditions like Down syndrome. However, it is essential to understand that while NIPT can indicate the likelihood of genetic conditions, it is not a diagnostic test. Therefore, a positive result should be followed up with further testing to confirm any findings. Many expectant parents appreciate the peace of mind NIPT provides, as it allows for earlier interventions or informed decision-making during pregnancy.
Who Should Consider NIPT?
NIPT is recommended for various groups, including women aged 35 and older, those with a history of genetic disorders, or anyone interested in early prenatal screening. Because NIPT is both safe and effective, many healthcare providers suggest it as a primary screening option for chromosomal abnormalities. The test can be performed as early as the 10th week of pregnancy, making it a proactive choice for parents-to-be who want to ensure the health of their baby.
By analysing small fragments of your baby’s DNA present in your blood, this test screens for a wide range of chromosomal conditions, including:
-
Down syndrome (Trisomy 21)
-
Edwards syndrome (Trisomy 18)
-
Patau syndrome (Trisomy 13)
-
Turner syndrome (Monosomy X)
-
Klinefelter syndrome
-
Jacobs syndrome
-
Autosomal aneuploidies, duplications & deletions
-
Gender identification (available for single pregnancies and identical twins)
Ongoing support
For complete peace of mind, free post-test genetic counselling is included if your results indicate an increased chance of a condition, ensuring you receive expert guidance and support when you need it most.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Understanding Non Invasive Prenatal Testing (NIPT)
Non Invasive Prenatal Testing (NIPT) - PrenatalSAFE Karyo is a groundbreaking method used to assess the risk of certain genetic disorders in a fetus, such as Down syndrome. This testing method is non-invasive, meaning that it involves a simple blood draw from the mother. Because of this, there are no risks associated with amniocentesis or chorionic villus sampling, which can be more invasive and carry potential complications. NIPT uses advanced DNA analysis to evaluate fragments of fetal DNA present in the mother's bloodstream, providing a reliable indicator of chromosomal abnormalities.
The Benefits of PrenatalSAFE Karyo
One of the main benefits of PrenatalSAFE Karyo is its high accuracy rate, often exceeding 99% in detecting conditions like Down syndrome. However, it is essential to understand that while NIPT can indicate the likelihood of genetic conditions, it is not a diagnostic test. Therefore, a positive result should be followed up with further testing to confirm any findings. Many expectant parents appreciate the peace of mind NIPT provides, as it allows for earlier interventions or informed decision-making during pregnancy.
Who Should Consider NIPT?
NIPT is recommended for various groups, including women aged 35 and older, those with a history of genetic disorders, or anyone interested in early prenatal screening. Because NIPT is both safe and effective, many healthcare providers suggest it as a primary screening option for chromosomal abnormalities. The test can be performed as early as the 10th week of pregnancy, making it a proactive choice for parents-to-be who want to ensure the health of their baby.
By analysing small fragments of your baby’s DNA present in your blood, this test screens for a wide range of chromosomal conditions, including:
-
Down syndrome (Trisomy 21)
-
Edwards syndrome (Trisomy 18)
-
Patau syndrome (Trisomy 13)
-
Turner syndrome (Monosomy X)
-
Klinefelter syndrome
-
Jacobs syndrome
-
Autosomal aneuploidies, duplications & deletions
-
Gender identification (available for single pregnancies and identical twins)
Ongoing support
For complete peace of mind, free post-test genetic counselling is included if your results indicate an increased chance of a condition, ensuring you receive expert guidance and support when you need it most.
















